Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Olfm3 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | 4,4'-sulfonyldiphenol | increases methylation | ISO | OLFM3 (Homo sapiens) | 6480464 | bisphenol S results in increased methylation of OLFM3 gene | CTD | PMID:31601247 | 6-propyl-2-thiouracil | decreases expression | ISO | Olfm3 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of OLFM3 mRNA | CTD | PMID:24780913 | acrylamide | decreases expression | ISO | OLFM3 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of OLFM3 mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases methylation | ISO | OLFM3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of OLFM3 gene | CTD | PMID:27153756 | aflatoxin B1 | increases methylation | ISO | OLFM3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of OLFM3 intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | OLFM3 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of OLFM3 mRNA | CTD | PMID:21934132 | all-trans-retinoic acid | increases expression | ISO | OLFM3 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of OLFM3 mRNA | CTD | PMID:23724009 | ammonium chloride | affects expression | ISO | Olfm3 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of OLFM3 mRNA | CTD | PMID:16483693 | atrazine | decreases expression | ISO | OLFM3 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of OLFM3 mRNA | CTD | PMID:22378314 | atrazine | affects methylation | ISO | Olfm3 (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of OLFM3 gene | CTD | PMID:35440735 | belinostat | increases expression | ISO | OLFM3 (Homo sapiens) | 6480464 | belinostat results in increased expression of OLFM3 mRNA | CTD | PMID:26272509 | benzo[a]pyrene | increases expression | ISO | OLFM3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of OLFM3 mRNA | CTD | PMID:22316170 | benzo[a]pyrene | affects methylation | ISO | OLFM3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of OLFM3 intron and Benzo(a)pyrene affects the methylation of OLFM3 promoter | CTD | PMID:27901495 and PMID:30157460 | benzo[a]pyrene | increases methylation | ISO | OLFM3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of OLFM3 5' UTR | CTD | PMID:27901495 | bisphenol A | decreases expression | ISO | Olfm3 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of OLFM3 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of OLFM3 mRNA | CTD | PMID:32156529 | bisphenol A | increases methylation | ISO | OLFM3 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of OLFM3 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | ISO | OLFM3 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of OLFM3 gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | Olfm3 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of OLFM3 mRNA | CTD | PMID:30816183 and PMID:32528016 | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of OLFM3 promoter | CTD | PMID:27312807 | bisphenol F | increases methylation | ISO | OLFM3 (Homo sapiens) | 6480464 | bisphenol F results in increased methylation of OLFM3 gene | CTD | PMID:31601247 | carbamazepine | affects expression | ISO | OLFM3 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of OLFM3 mRNA | CTD | PMID:25979313 | copper atom | increases expression | ISO | Olfm3 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of OLFM3 mRNA | CTD | PMID:26033743 | copper(0) | increases expression | ISO | Olfm3 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of OLFM3 mRNA | CTD | PMID:26033743 | dorsomorphin | multiple interactions | ISO | OLFM3 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | increases expression | ISO | OLFM3 (Homo sapiens) | 6480464 | entinostat results in increased expression of OLFM3 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | OLFM3 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLFM3 mRNA | CTD | PMID:27188386 | ethanol | multiple interactions | ISO | OLFM3 (Homo sapiens) | 6480464 | [Ethanol co-treated with Folic Acid] results in increased expression of OLFM3 mRNA | CTD | PMID:23378141 | ethanol | affects expression | EXP | | 6480464 | Ethanol affects the expression of OLFM3 mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | ISO | OLFM3 (Homo sapiens) | 6480464 | [Ethanol co-treated with Folic Acid] results in increased expression of OLFM3 mRNA | CTD | PMID:23378141 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of OLFM3 mRNA | CTD | PMID:25629700 | fulvestrant | multiple interactions | ISO | OLFM3 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of OLFM3 gene | CTD | PMID:31601247 | fulvestrant | decreases methylation | ISO | OLFM3 (Homo sapiens) | 6480464 | Fulvestrant results in decreased methylation of OLFM3 gene | CTD | PMID:31601247 | lead(0) | affects expression | ISO | OLFM3 (Homo sapiens) | 6480464 | Lead affects the expression of OLFM3 mRNA | CTD | PMID:28903495 | mercury dibromide | multiple interactions | ISO | OLFM3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OLFM3 mRNA | CTD | PMID:27188386 | methoxychlor | affects methylation | ISO | Olfm3 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of OLFM3 gene | CTD | PMID:35440735 | methylmercury chloride | decreases expression | ISO | OLFM3 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of OLFM3 mRNA | CTD | PMID:26272509 and PMID:28001369 | O-methyleugenol | decreases expression | ISO | OLFM3 (Homo sapiens) | 6480464 | methyleugenol results in decreased expression of OLFM3 mRNA | CTD | PMID:32234424 | p-chloromercuribenzoic acid | decreases expression | ISO | OLFM3 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of OLFM3 mRNA | CTD | PMID:26272509 | panobinostat | multiple interactions | ISO | OLFM3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLFM3 mRNA | CTD | PMID:27188386 | panobinostat | increases expression | ISO | OLFM3 (Homo sapiens) | 6480464 | panobinostat results in increased expression of OLFM3 mRNA | CTD | PMID:26272509 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of OLFM3 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | OLFM3 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of OLFM3 mRNA | CTD | PMID:26690555 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of OLFM3 mRNA | CTD | PMID:19710929 | resveratrol | multiple interactions | ISO | OLFM3 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of OLFM3 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | ISO | OLFM3 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | tamoxifen | decreases expression | EXP | | 6480464 | Tamoxifen results in decreased expression of OLFM3 mRNA | CTD | PMID:25123088 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of OLFM3 mRNA | CTD | PMID:31919559 | titanium dioxide | decreases expression | EXP | | 6480464 | titanium dioxide results in decreased expression of OLFM3 mRNA | CTD | PMID:29264374 | trichostatin A | increases expression | ISO | OLFM3 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of OLFM3 mRNA | CTD | PMID:24935251 and PMID:26272509 | Triptolide | decreases expression | EXP | | 6480464 | triptolide results in decreased expression of OLFM3 mRNA | CTD | PMID:32835833 | valproic acid | affects expression | ISO | OLFM3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of OLFM3 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | OLFM3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of OLFM3 mRNA | CTD | PMID:28001369 | valproic acid | increases expression | ISO | OLFM3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of OLFM3 mRNA | CTD | PMID:24383497 and PMID:24935251 | vancomycin | increases expression | EXP | | 6480464 | Vancomycin results in increased expression of OLFM3 mRNA | CTD | PMID:18930951 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
